NCT03880058View on ClinicalTrials.gov

Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 3, 2019

Primary Completion Date

May 18, 2021

Study Completion Date

May 18, 2021

Conditions
Scars
Interventions
DRUG

SLI-F06

Active treatment

DRUG

Formulation buffer

Placebo treatment

Trial Locations (3)

19004

Site 3, Bala-Cynwyd

63110

Site 2, St Louis

60611-2950

Site 1, Chicago

All Listed Sponsors
collaborator

ethica Clinical Research Inc.

INDUSTRY

lead

Scarless Laboratories, Inc.

INDUSTRY

NCT03880058 - Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance | Biotech Hunter | Biotech Hunter